Insider Selling: Liquidia (NASDAQ:LQDA) General Counsel Sells 13,692 Shares of Stock

Key Points

• General Counsel Russell Schundler sold 13,692 shares on April 13 at an average price of $38.37 for $525,362, executing the trade under a pre-arranged Rule 10b5-1 plan to cover tax withholding; his stake fell 2.19% to 610,532 shares (≈$23.4M).
• Liquidia shares traded around $38.71 (down ~0.4%) with a market cap of $3.41B and a 12‑month range of $11.85–$46.67; the company reported a quarterly beat (EPS $0.15 vs $0.08, revenue $92.0M) but still shows negative net margin and ROE.
• Analysts are mixed but generally positive: consensus rating is a Moderate Buy with an average target of $43.44, while institutional ownership is high (≈64.5%) and several funds recently increased positions.

Liquidia Corporation (NASDAQ:LQDA - Get Free Report) General Counsel Russell Schundler sold 13,692 shares of the business's stock in a transaction on Monday, April 13th. The shares were sold at an average price of $38.37, for a total transaction of $525,362.04. Following the transaction, the general counsel owned 610,532 shares in the company, valued at $23,426,112.84. The trade was a 2.19% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Liquidia Stock Down 0.4%

NASDAQ:LQDA traded down $0.14 during trading hours on Tuesday, reaching $38.71. The company had a trading volume of 844,813 shares, compared to its average volume of 1,775,539. Liquidia Corporation has a twelve month low of $11.85 and a twelve month high of $46.67. The company has a quick ratio of 1.84, a current ratio of 2.01 and a debt-to-equity ratio of 2.97. The firm has a market cap of $3.41 billion, a price-to-earnings ratio of -46.64 and a beta of 0.45. The business's 50-day simple moving average is $36.87 and its two-hundred day simple moving average is $32.92.

Liquidia (NASDAQ:LQDA - Get Free Report) last announced its quarterly earnings data on Thursday, March 5th. The company reported $0.15 earnings per share for the quarter, beating the consensus estimate of $0.08 by $0.07. The firm had revenue of $92.02 million for the quarter, compared to analyst estimates of $87.49 million. Liquidia had a negative net margin of 43.53% and a negative return on equity of 209.33%. The business's quarterly revenue was up 3072.4% compared to the same quarter last year. On average, equities analysts expect that Liquidia Corporation will post -1.51 earnings per share for the current year.

Institutional Trading of Liquidia

Several institutional investors and hedge funds have recently modified their holdings of LQDA. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of Liquidia by 4.7% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 37,681 shares of the company's stock worth $556,000 after purchasing an additional 1,700 shares during the last quarter. Goldman Sachs Group Inc. boosted its position in shares of Liquidia by 10.7% during the first quarter. Goldman Sachs Group Inc. now owns 861,231 shares of the company's stock valued at $12,703,000 after buying an additional 82,955 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in Liquidia by 15.2% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 121,756 shares of the company's stock worth $1,796,000 after buying an additional 16,022 shares in the last quarter. Creative Planning raised its position in Liquidia by 40.7% in the 2nd quarter. Creative Planning now owns 26,840 shares of the company's stock valued at $334,000 after buying an additional 7,765 shares during the last quarter. Finally, Legal & General Group Plc raised its position in Liquidia by 13.4% in the 2nd quarter. Legal & General Group Plc now owns 94,152 shares of the company's stock valued at $1,174,000 after buying an additional 11,111 shares during the last quarter. 64.54% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on the company. Oppenheimer increased their price target on Liquidia from $16.00 to $19.00 and gave the stock an "underperform" rating in a report on Thursday, March 12th. Raymond James Financial reaffirmed a "strong-buy" rating on shares of Liquidia in a research report on Thursday, March 5th. Lifesci Capital upgraded Liquidia to a "strong-buy" rating in a report on Thursday, March 5th. HC Wainwright lifted their price target on shares of Liquidia from $50.00 to $55.00 and gave the company a "buy" rating in a research report on Friday, March 6th. Finally, Wells Fargo & Company boosted their price target on shares of Liquidia from $44.00 to $51.00 and gave the company an "overweight" rating in a research note on Monday, March 23rd. Two research analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating, one has issued a Hold rating and two have given a Sell rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $43.44.

Liquidia Company Profile

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company's lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.